Apolipoprotein E (apoE) plays a critical role in lipid transport and brain homeostasis, with APOE epsilon4 allele representing the strongest genetic risk factor for late-onset Alzheimer's disease. This category covers therapeutic approaches targeting apoE biology and related lipid transport pathways.
APOE Biology in Alzheimer's Disease
APOE Gene and Protein
The APOE gene (chromosome 19q13.32) encodes a 299-amino acid glycoprotein produced primarily by astrocytes in the brain. Three common alleles (ε2, ε3, ε4) encode proteins with different functional properties:
Mechanisms of APOE in AD
Amyloid metabolism: ApoE binds Aβ and influences its aggregation, clearance, and deposition
Lipid homeostasis: ApoE mediates cholesterol and phospholipid transport between cells
Neuroinflammation: ApoE4 triggers microglial activation and pro-inflammatory responses
Synaptic function: ApoE affects synaptic plasticity and neuronal repair
Tau pathology: Interactions between apoE and tau neurodegeneration pathways
Mechanism: Antibodies targeting apoE can reduce amyloid burden by enhancing microglial clearance of Aβ-apoE complexes and preventing plaque formation.
APOE Gene Therapy
Lexeo Therapeutics is developing LX1001, an AAV-based gene therapy delivering protective APOE2 to APOE4 homozygotes. This approach aims to reduce AD risk in high-risk individuals.
ABCA1/ABCG1 Modulators
ATP-binding cassette transporters ABCA1 and ABCG1 regulate cellular cholesterol efflux and apoE lipidation. Enhancing their function may improve apoE function and Aβ clearance.
Lipid Metabolism Modulators
Denali Therapeutics is developing programs targeting APOE biology and lipid homeostasis:
LY3372689 (LOTUS)
While primarily an OGA inhibitor, Lilly's LY3372689 has additional activities affecting lipid metabolism and may provide benefits through multiple mechanisms.
[Mahley, R. W., et al. Apolipoprotein E: From atherosclerosis to Alzheimer's disease and beyond. Journal of Molecular Medicine (2006)](https://doi.org/10.1007/s00109-006-0094-1)
[Kim, J., et al. Functions of apoE in the central nervous system in health and disease. Neurochemical Research (2012)](https://doi.org/10.1007/s11064-012-0851-9)
[Risacher, S. L., et al. Association of APOE genotype and progression of Alzheimer's disease. Journal of Alzheimer's Disease (2019)](https://doi.org/10.3233/JAD-180975)
[Hudry, E., et al. ApoE antibody enhances amyloid clearance and prevents plaque formation. Science Translational Medicine (2020)](https://doi.org/10.1126/scitranslmed.abb2877)
Related Hypotheses
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate